1. Home
  2. VERU vs YGMZ Comparison

VERU vs YGMZ Comparison

Compare VERU & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • YGMZ
  • Stock Information
  • Founded
  • VERU 1971
  • YGMZ 2002
  • Country
  • VERU United States
  • YGMZ China
  • Employees
  • VERU N/A
  • YGMZ N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • VERU Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • VERU 54.6M
  • YGMZ 57.6M
  • IPO Year
  • VERU 1990
  • YGMZ 2020
  • Fundamental
  • Price
  • VERU $4.29
  • YGMZ $0.69
  • Analyst Decision
  • VERU Strong Buy
  • YGMZ
  • Analyst Count
  • VERU 3
  • YGMZ 0
  • Target Price
  • VERU $33.33
  • YGMZ N/A
  • AVG Volume (30 Days)
  • VERU 158.4K
  • YGMZ 254.6K
  • Earning Date
  • VERU 08-12-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • VERU N/A
  • YGMZ N/A
  • EPS Growth
  • VERU N/A
  • YGMZ N/A
  • EPS
  • VERU N/A
  • YGMZ N/A
  • Revenue
  • VERU $16,886,419.00
  • YGMZ $40,429,750.00
  • Revenue This Year
  • VERU N/A
  • YGMZ N/A
  • Revenue Next Year
  • VERU N/A
  • YGMZ N/A
  • P/E Ratio
  • VERU N/A
  • YGMZ N/A
  • Revenue Growth
  • VERU 337.24
  • YGMZ N/A
  • 52 Week Low
  • VERU $2.64
  • YGMZ $0.63
  • 52 Week High
  • VERU $14.20
  • YGMZ $1.77
  • Technical
  • Relative Strength Index (RSI)
  • VERU 74.55
  • YGMZ 41.81
  • Support Level
  • VERU $3.75
  • YGMZ $0.68
  • Resistance Level
  • VERU $3.99
  • YGMZ $0.77
  • Average True Range (ATR)
  • VERU 0.24
  • YGMZ 0.04
  • MACD
  • VERU -0.01
  • YGMZ -0.00
  • Stochastic Oscillator
  • VERU 94.34
  • YGMZ 8.77

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.

Share on Social Networks: